from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2621c/-

LFCtreatmentdescriptionclass of inhibitor

-0.272

Amikacinug/mL Amikacintranslation

-0.289

Cap5-10ug/mL Capreomycintranslation

-0.097

Rox10-50 ug/mL Roxithromycintranslation

-0.412

SM2-5 ug/mL Streptomycintranslation

-0.281

Tet5-10 ug/mL Tetracyclinetranslation

-0.171

Rif0.2-5ug/mL Rifampicintranscription

-0.830

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.906

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.291

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.112

CPZ10-50 ug/mL Chlorpromazinerespiration

1.496

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.458

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.778

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.317

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.491

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.339

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.800

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.503

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

5.118

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.329

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.901

KCN5-20 ug/mL Potassium cyaniderespiration

-0.218

NaN30.2-2 mM Sodium aziderespiration

-0.548

Nigericin50 uM Nigericinrespiration

0.220

TRC10-150 ug/mL Triclosanrespiration

0.467

TRZ10-25 ug/mL Thioridazinerespiration

2.099

Valinomycin0.5-10 uM Valinomycinrespiration

-0.614

ZnSO42 mM ZnSO4respiration

0.487

menadione6-10 ug/mL Menadionerespiration

-0.261

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.088

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.009

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

2.257

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.192

NRP_1Non-replicating persistence stage 1dosRassociated

-0.769

Amp0.2mg/mL AmpicillincellWall

-0.287

Cephalexin20-100 ug/mL CephalexincellWall

0.203

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.517

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.209

EMB10-20 ug/mL EthambutolcellWall

-0.355

Eta12-40 ug/mL EthionamidecellWall

-0.587

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.150

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.614

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.764

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.106

BZA0.12 mg/mL BenzamidearomaticAmides

-0.018

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.362

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.184

H2O24 mM hydrogen peroxideDNAdamaging

-0.476

Levo10 ug/mL LevofloxacinDNAdamaging

-0.473

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.334

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.724

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.704

UVUV-irradiationDNAdamaging

0.849

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.760

Antimycin12.5-50 ug/mL Antimycin A?

-0.424

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.395

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.374

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.020

PA8240.2-2 ug/mL PA-824?

0.802

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.279

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.807

Verapamil50 uM Verapamil?

-0.802

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.258

methoxatin10-20 ug/mL Methoxatin?